paclitaxel has been researched along with Coronary Occlusion in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 14 (77.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Dandona, S; Daneault, B; Rinfret, S; Ybarra, LF | 1 |
| Kobayashi, I; Niwa, A; Onishi, T; Onishi, Y; Umezawa, S | 1 |
| Liu, Q; Wang, H; Xie, Q; Yang, X; Yuan, L | 1 |
| Brilakis, ES; Garcia, S | 1 |
| de la Torre Hernández, JM; Garcia-Camarero, T; Lee, DH; Sainz Laso, F; Zueco, J | 1 |
| Buccheri, D; Cortese, B; Piraino, D; Seregni, R; Silva-Orrego, P | 1 |
| Chae, IH; Gwon, HC; Hur, SH; Jang, Y; Kang, SH; Kim, HS; Kim, MH; Lee, JM; Lee, MH; Lee, SH; Park, HS; Rha, SW; Yoon, CH; Yu, CW | 1 |
| Kadota, J; Miyamoto, K; Tamura, A; Watanabe, T | 1 |
| Akin, I; Fetsch, T; Kuck, KH; Nienaber, CA; Richardt, G; Sabin, GV; Schneider, S; Senges, J; Silber, S; Stumpf, J; Tebbe, U; Willich, SN | 1 |
| Almonacid, A; Kirtane, A; Leon, MB; Mauri, L; McLaurin, B; O'Shaughnessy, C; Overlie, P; Popma, JJ | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Kang, HJ; Kim, HS; Kim, SY; Koo, BK; Lee, SP; Park, KW; Shin, DH; Suh, JW; Yeon, TJ | 1 |
| Agostoni, P; Banerjee, S; Brilakis, ES; Kandzari, DE; Lombardi, WL; Rangan, BV; Saeed, B | 1 |
| Suzuki, M; Takagi, Y; Tsuchikane, E | 1 |
| Bowman, TS; Cox, DA; Dawkins, KD; Huang, PH; Lasala, JM; Starzyk, RM; Yeung, M | 1 |
| Desale, S; Ellis, SG; Grube, E; Laynez-Carnicero, A; Mintz, GS; Ormiston, JA; Pakala, R; Pichard, AD; Romaguera, R; Sardi, G; Stone, GW; Turco, MA; Wakabayashi, K; Waksman, R; Weissman, NJ; Xue, Z | 1 |
| Werner, GS; Wöhrle, J | 1 |
| Udaya Prashant, P | 1 |
| De Felice, F; Dibra, A; Fiorilli, R; Menichelli, M; Musto, C; Nazzaro, MS; Parma, A; Pucci, E; Violini, R | 1 |
2 review(s) available for paclitaxel and Coronary Occlusion
| Article | Year |
|---|---|
Comparison of Limus-Eluting and Paclitaxel-Eluting Stents for Coronary Intervention in Patients with Chronic Kidney Disease.
Topics: Antineoplastic Agents; Coronary Occlusion; Drug-Eluting Stents; Humans; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Renal Insufficiency, Chronic; Sirolimus; Treatment Outcome | 2018 |
Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Patient Selection; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
3 trial(s) available for paclitaxel and Coronary Occlusion
| Article | Year |
|---|---|
Comparison of outcomes after percutaneous coronary intervention for chronic total occlusion using everolimus- versus sirolimus- versus paclitaxel-eluting stents (from the Korean National Registry of Chronic Total Occlusion Intervention).
Topics: Antineoplastic Agents; Chronic Disease; Coronary Angiography; Coronary Occlusion; Drug-Eluting Stents; Electrocardiography; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Registries; Republic of Korea; Retrospective Studies; Sirolimus; Survival Rate; Treatment Outcome | 2015 |
Impact of drug-eluting stents on distal vessels.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Ultrasonography, Interventional; Wound Healing | 2012 |
Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Coated Materials, Biocompatible; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Equipment Design; Female; Germany; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Stents; Time Factors; Treatment Outcome | 2013 |
13 other study(ies) available for paclitaxel and Coronary Occlusion
| Article | Year |
|---|---|
Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Chronic Disease; Coated Materials, Biocompatible; Coronary Occlusion; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Stents; Treatment Failure | 2020 |
Drug-coated balloon angioplasty for de novo small vessel disease including chronic total occlusion and bifurcation in real-world clinical practice.
Topics: Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Coronary Restenosis; Female; Humans; Japan; Male; Paclitaxel | 2019 |
Optimal stenting strategy for coronary chronic total occlusion interventions: what is next?
Topics: Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Occlusion; Female; Humans; Male; Metals; Paclitaxel; Stents | 2013 |
Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography.
Topics: Aged; Aged, 80 and over; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Tomography, Optical Coherence; Treatment Outcome | 2013 |
Drug-coated balloon angioplasty: An intriguing alternative for the treatment of coronary chronic total occlusions.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Occlusion; Humans; Male; Paclitaxel | 2015 |
Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Prosthesis Failure; Recurrence; Retreatment; Sirolimus | 2010 |
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Occlusion; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Sirolimus; Stents; Stroke | 2009 |
Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Creatine Kinase, MB Form; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardium; Necrosis; Paclitaxel; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Long-term clinical outcome of chronic total occlusive lesions treated with drug-eluting stents: comparison of sirolimus-eluting and paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cohort Studies; Coronary Angiography; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Recurrence; Registries; Sirolimus; Treatment Failure; Treatment Outcome | 2010 |
Percutaneous coronary intervention of chronic total occlusion in a left anterior descending coronary artery using an ipsilateral intraseptal bridging collateral tracking technique.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chronic Disease; Collateral Circulation; Coronary Angiography; Coronary Circulation; Coronary Occlusion; Drug-Eluting Stents; Humans; Male; Paclitaxel; Treatment Outcome | 2010 |
Two-year clinical outcomes with paclitaxel-eluting coronary stents in patients with chronic total occlusions: analysis from the TAXUS ARRIVE program.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cohort Studies; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prospective Studies; Registries; Time Factors; Treatment Outcome | 2011 |
Successful angioplasty of anomalous coronary arteries with total occlusions.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Occlusion; Coronary Vessel Anomalies; Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Stents; Treatment Outcome | 2012 |
Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Angiography; Coronary Occlusion; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Prognosis; Proportional Hazards Models; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2009 |